Electroacupuncture ameliorates depression-like behaviors in rats with post-stroke depression by inhibiting ferroptosis in the prefrontal cortex

Jing Gao, Xiaolei Song, Yixuan Feng, Lihua Wu, Zhimin Ding, Shikui Qi, Mingyue Yu, Ruonan Wu, Xinyue Zheng, Yanyan Qin, Yuchuang Tang, Mengyu Wang, Xiaodong Feng, Qiongshuai ZhangFrontiers in Neuroscience 2024 · DOI

TL;DR

This study investigates electroacupuncture (EA) as a treatment for post-stroke depression (PSD) in rats. Researchers found that EA effectively reduced depression-like behaviors and mitigated neuronal damage by inhibiting ferroptosis, a specific type of cell death, in the prefrontal cortex. This suggests EA could be a promising therapeutic strategy for PSD by targeting ferroptosis pathways.

What Problem Does This Paper Address?

Post-stroke depression (PSD) is a common and debilitating complication following a stroke, significantly hindering recovery. Despite its prevalence, the underlying mechanisms of PSD are not fully understood, making effective treatment challenging. Recent research has implicated ferroptosis, a form of programmed cell death characterized by iron-dependent lipid peroxidation, in both stroke pathology and depression. This paper aims to explore whether ferroptosis plays a role in PSD and if electroacupuncture (EA), a traditional Chinese medicine technique, can alleviate PSD symptoms by modulating ferroptosis in the prefrontal cortex, a brain region crucial for mood regulation.

Methods

The researchers employed a multi-faceted approach to model PSD and evaluate the effects of EA.

  • PSD Modeling: Male Sprague-Dawley rats were subjected to a combination of middle cerebral artery occlusion (MCAO) to induce stroke and chronic unpredictable mild stress (CUMS) to mimic the depressive state.
  • EA Treatment: Rats received EA treatment for 14 consecutive days, with sessions lasting 30 minutes daily.
  • Ferroptosis Manipulation: To specifically investigate the role of ferroptosis, the study used:
  • Ferrostatin-1 (Fer-1): A known ferroptosis inhibitor, administered in Experiment 1 as a positive control.
  • Erastin: A ferroptosis inducer, administered in Experiment 2 to exacerbate ferroptosis and then assess EA's ability to counteract these effects.
  • Behavioral Assessments: A battery of tests was used to evaluate depression-like behaviors and neurological deficits:
  • Zea-Longa Score: Assessed neurological deficits post-MCAO.
  • Sucrose Preference Test (SPT): Measured anhedonia (loss of pleasure).
  • Open-Field Test (OFT): Evaluated general activity and anxiety.
  • Elevated Plus Maze Test (EPMT): Assessed anxiety-like behaviors.
  • Histological and Molecular Analyses:
    • Hematoxylin-Eosin (HE) and Nissl Staining: Examined general neuronal morphology and structure.
  • Perl's Staining: Visualized iron deposition in neurons.
  • Transmission Electron Microscopy (TEM): Provided detailed ultrastructural analysis of mitochondria, a key indicator of ferroptosis.
  • Colorimetric Assays and ELISA: Measured levels of oxidative stress markers (MDA, T-SOD, CAT, GSH, ROS) and ferrous iron (Fe2+).
  • Western Blotting (WB): Quantified the expression of key proteins involved in ferroptosis, iron metabolism, and antioxidant defense (e.g., FTH-1, FTL, SLC7A11, GPX4, ACSL4, LOX).

Datasets

Not discussed in the paper. The study utilized animal models and performed various experimental measurements.

Key Insights and Ideas

  • Ferroptosis as a Key Player in PSD: The study strongly suggests that ferroptosis, beyond its known role in stroke, is a significant contributor to the development of depression-like behaviors in the context of PSD.
  • EA's Dual Action: EA appears to exert its antidepressant effects through a dual mechanism: directly improving neurological function and mood, and crucially, by inhibiting the ferroptotic cell death pathway in the prefrontal cortex.
  • Prefrontal Cortex Vulnerability: The prefrontal cortex is identified as a critical site where ferroptosis occurs in PSD, and its structural and functional integrity is directly linked to the observed behavioral improvements with EA.
  • Erastin as a Tool: The use of erastin, a ferroptosis inducer, was instrumental in confirming EA's inhibitory role. By exacerbating ferroptosis and then showing EA's ability to reverse these negative effects, the study provides strong evidence for EA's mechanism of action.

Key Results

  • Behavioral Improvements: EA treatment significantly reduced neurological deficits and improved depression-like behaviors, as evidenced by increased sucrose preference, increased distance traveled in the OFT, and increased open arm time in the EPMT.
  • Neuronal Protection: EA treatment mitigated neuronal damage and apoptosis in the prefrontal cortex, similar to the effects of the ferroptosis inhibitor Fer-1.
  • Ferroptosis Inhibition: EA significantly reduced iron deposition and lipid peroxidation in the prefrontal cortex. It also restored the balance of oxidative stress markers (decreasing MDA and ROS, increasing T-SOD, CAT, and GSH).
  • Molecular Pathway Modulation: EA treatment reversed the altered expression of ferroptosis-related proteins, decreasing pro-ferroptotic proteins (ACSL4, LOX) and increasing anti-ferroptotic proteins (SLC7A11, GPX4, FTH-1, FTL).
  • Mitochondrial Health: TEM analysis showed that EA treatment improved mitochondrial morphology, which was severely damaged in PSD rats and further worsened by erastin.

Limitations and Future Work

  • Translational Potential: While promising, the study was conducted in an animal model. Further research is needed to confirm these findings in human patients and explore the optimal EA parameters for clinical application.
  • Specificity of EA Points: The paper focuses on specific acupuncture points. Future work could investigate the differential effects of EA applied to other points or combinations of points.
  • Long-term Effects: The study primarily focused on a 14-day EA treatment period. Investigating the long-term efficacy and sustainability of EA's effects would be valuable.
  • Detailed Molecular Mechanisms: While key proteins were identified, a deeper dive into the precise molecular cascades linking EA, ferroptosis, and neuronal protection could provide further insights. The authors suggest that EA's effectiveness in treating PSD by inhibiting ferroptosis provides theoretical evidence for its use as a rehabilitation strategy.

Summary updated

Abstract

EA improved depression-like behaviors, mitigated mitochondrial damage, and inhibited ferroptosis in prefrontal cortex neurons. Notably, the administration of erastin further enhanced these effects. In conclusion, EA appears to improve PSD by inhibiting ferroptosis in the prefrontal cortex.
BibTeX
@inproceedings{gao2024electroacupuncture,
  author = {Jing Gao and Xiaolei Song and Yixuan Feng and Lihua Wu and Zhimin Ding and Shikui Qi and Mingyue Yu and Ruonan Wu and Xinyue Zheng and Yanyan Qin and Yuchuang Tang and Mengyu Wang and Xiaodong Feng and Qiongshuai Zhang},
  title = {{Electroacupuncture ameliorates depression-like behaviors in rats with post-stroke depression by inhibiting ferroptosis in the prefrontal cortex}},
  booktitle = {Frontiers in Neuroscience},
  year = {2024},
  doi = {10.3389/fnins.2024.1422638},
}
Figure